Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Tonia Vincent, of the Kennedy Institute of Rheumatology, discusses osteoarthritis of the hand on Radio 4's Woman's Hour.

Professor Vincent joined presenter Jenni Murray and patient Linda Muller to talk about arthritis of the hand, why it is most common in women after the menopause and whether the condition can be prevented or treated.

Asked if there are any supplements that could be recommended, Professor Vincent said: "I say to patients they should try anything that they think might work and if it works they should continue to take it, but there is nothing proven in any clinical trials."

Professor of Musculoskeletal Biology at the University of Oxford, Tonia Vincent is also a consultant rheumatologist and Director of the Arthritis Research UK Centre for Osteoarthritis Pathogenesis, Oxford.

Listen to the full programme here, hand arthritis feature at 37'. 

Similar stories

The Duchess of Cornwall opens the new Marcela Botnar wing

A new building at the University of Oxford's Botnar Institute for Musculoskeletal Sciences has been opened by The Duchess of Cornwall.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.